Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-02-08 | Graves’ Disease | ETA2023

Evaluation of paraoxonase (PON-1) activity and advanced glycation end-products (AGES) as reliable markers of oxidative stress in graves’ disease patients

Lagana Martina , Teresa Cristani Maria , Sofia Molonia Maria , Burduja Nina , Campenni Alfredo , Cannavo Salvatore , Ruggeri Rosaria

Objective: Oxidative stress has been implicated in the pathogenesis of hyperthyroidism, and its complications. Advanced glycation end products (AGEs), compounds derived from non-enzymatic transformation of macromolecules, are able to increase oxidative stress and promote inflammation and are increased in several oxidative stress-related disorders, including autoimmune thyroiditis. In the same diseases, the activity of paraoxonase-1 (PON-1), an anti-oxidant enzyme protecting ag...

ea0090oc12.7 | Oral Communications 12: Environmental Endocrinology | ECE2023

Polychlorinated biphenyls (PCBs) modulate AHR pathways leading to the altered expression of genes involved in extra-cellular matrix (ECM) remodeling and epigenetic regulation in thyrocytes

Minuti Aurelio , Aliquo Federica , Giani Fiorenza , Lagana Martina , Ragonese Marta , Avenoso Angela , Cannavo Salvatore , Scuruchi Michele , D'Ascola Angela , Ruggeri Rosaria

Background: PCBs are chemical pollutants able to promote inflammation and carcinogenesis. They can accumulate in human tissues through the food chain causing a variety of adverse health effects. The NF-E2 p45-related factor 2 (NRF2) and the aryl hydrocarbon receptor (AHR) are ligand activated transcription factors controlling pathways modulating xenobiotic metabolism. Increasing evidence indicate the involvement of AhR in regulating extracellular matrix (ECM) homeostasis. ECM ...

ea0090rc5.2 | Rapid Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

Analysis of germline mutations in patients with non-syndromic adrenocortical carcinoma

Terzolo Massimo , Grisanti Salvatore , Scatolini Maria , Tomaiuolo Pasquale , Grosso Enrico , Basile Vittoria , Cosentini Deborah , Puglisi Soraya , Lagana Marta , Perotti Paola , Rossini Elisa , Sigala Sandra , Volante Marco , Berruti Alfredo

Background: Adrenocortical carcinoma (ACC) is a rare cancer associated with hereditary syndromes in 10% of cases. However, data on germline variants (GVs) in adult patients with sporadic ACC are limited.Methods: We analyzed germline DNA from 150 adult patients with sporadic ACC sequentially referred to our centers between 1998-2019. We designed a custom panel of 17 genes potentially involved in the pathogenesis of ACC: AIP, APC, ARMC5, ARNT, BRCA1, BRCA2...

ea0056p199 | Bone ' Osteoporosis | ECE2018

Long term follow up of patients with hypophosphatemic rickets in a Public Institution in Brazil

Vieira Oberger Marques Julia , Cervi Lagana Caio , Frare Junior Neudir , Oliboni Do Amaral Patricia , Besen Debora , Robl Marcela , Zegbi Cochenski Borba Victoria , Aguiar Moreira Carolina

Introduction: Hypophosphatemic rickets comprehends a group of hereditary diseases characterized by hypophosphatemia and defective bone mineralization. The most common form is X-linked, with a prevalence of 1:20.000.Objectives: Describe the follow up of patients with hypophosphatemic rickets in a public center in Brazil.Methods: Patients with hypophosphatemic rickets were selected from a database of Endocrinology and Metabolism Serv...

ea0056p1101 | Thyroid (non-cancer) | ECE2018

Dysthyroid optic neuropathy in Grave’s disease: two case reports

Marques Julia Vieira Oberger , Lagana Caio Cesar Cervi , Junior Neudir Frare , Amaral Patricia Oliboni Do , Robl Marcela , Besen Debora Cristina , Junior Cleo Mesa , Amaral Gisah Do , Graf Hans

Introduction: Ophthalmopathy is the most common extrathyroidal manifestation of Grave’s disease, with 3–7% evolving to Dysthyroid Optic Neuropathy (DON), which requires urgent treatment to avoid permanent or progressive visual loss. We describe two cases of DON evaluated at Endocrinology and Metabolism Service of Paraná (SEMPR).Case 1: Male, 70 years old, previously diagnosed with hypertension, type 2 diabetes with insulin use, microvascul...

ea0093oc17 | Oral communication 3: Adrenal Tumors and Neuroendocrine Tumors | EYES2023

Preclinical and clinical evidence of progesterone/megestrol acetate activity in metastatic adrenocortical carcinoma

Tamburello Mariangela , Abate Andrea , Turla Antonella , Lagana Marta , Rossini Elisa , Hantel Constanze , Tiberio Guido Alberto Massimo , Cosentini Deborah , Grisanti Salvatore , Berruti Alfredo , Sigala Sandra

Background: Adrenocortical carcinoma (ACC) is a rare cancer for which available systemic treatments, mitotane ± etoposide, doxorubicin and cisplatin (EDP-M), have limited efficacy.Objectives: Here, we strengthen the effect of progesterone (Pg) on metastatic ACC cell lines, studying whether it could influence growth, invasiveness, and metastasis formation. Additionally, we investigate if the Pg analogue megestrol-acetate administered with EDP-M could...

ea0081oc2.6 | Oral Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Activity of abiraterone acetate in the management of cushing syndrome associated to advanced adrenocortical carcinoma: results of the ABACUS trial

Puglisi Soraya , Cosentini Deborah , Grisanti Salvatore , Basile Vittoria , Lagana Marta , Ferarri VittorioDomenico , Abate Andrea , Calabrese Anna , Rossini Elisa , Perotti Paola , Saba Laura , Pia Anna , Sigala Sandra , Berruti Alfredo , Terzolo Massimo

Background: More than 50% of adrenocortical carcinomas (ACC) in adults are associated with cortisol excess that makes tumor management challenging and has a negative impact on patient outcome. Abiraterone acetate (AA) is an irreversible inhibitor of the 17α-hydroxylase/C17, 20-lyase (CYP17 enzyme) that is used in patients with prostate cancer, in whom it leads to suppression of cortisol and androgens. The aim of this study was to assess the activity of AA to control corti...